“High LAG3 Expression Linked to Favorable Prognosis, Potential Biomarker in Cutaneous Melanoma Regulation by Tumor-Infiltrating Immune Cells”

https://pubmed.ncbi.nlm.nih.gov/38115039

This study reveals that high LAG3 expression is associated with favorable prognosis in cutaneous melanoma and may serve as a potential biomarker, and that LAG3 plays a crucial regulatory role in tumor-infiltrating immune cells.